Mechanism of the interferon alpha response against hepatitis C virus replicons

Virology
Ju-Tao GuoChristoph Seeger

Abstract

Interferon alpha (IFN-alpha) inhibits hepatitis C virus (HCV) replication in vivo and in cell cultures by one or several mechanisms that are not yet understood. We sought to identify the viral targets of the IFN-alpha-induced cellular antiviral program in Huh7 cells expressing HCV subgenomic replicons. Our results revealed a tight linkage between translation, assembly of replication complexes and viral RNA synthesis, and indicated that the stability of amplified plus strand RNA was reduced in the presence of the cytokine. Moreover, HCV internal ribosomal entry site (IRES)-directed translation was inhibited approximately 2-fold in IFN-treated cells. In contrast, the synthesis of viral RNA did not seem to be directly affected by the antiviral program induced by the cytokine. Our results were consistent with a model predicting that the IFN-alpha-induced antiviral program could inhibit multiple steps of the HCV replication cycle, leading to a reduction in viral protein synthesis and eventually inhibition of viral RNA amplification.

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y K ShimizuH Yoshikura
Oct 6, 1998·Annual Review of Biochemistry·G R StarkR D Schreiber
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·S D DerR H Silverman
Dec 9, 2000·Science·K J BlightC M Rice
Jan 11, 2001·Journal of Virology·T PietschmannR Bartenschlager
Mar 21, 2001·The Journal of General Virology·M FreseR Bartenschlager
Jun 20, 2001·Journal of Virology·A A KhromykhE G Westaway
Aug 17, 2001·Journal of Virology·J T GuoC Seeger
Sep 7, 2001·Annual Review of Microbiology·G C Sen
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Takeo ShimazakiKenichi Kobayashi
Jan 30, 2003·The Journal of Biological Chemistry·Steven S CarrollDavid B Olsen
Sep 12, 1957·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·A ISAACS, J LINDENMANN

❮ Previous
Next ❯

Citations

Jul 5, 2007·Journal of Virology·Kyeong-Ok Chang, David W George
Jul 10, 2009·The Journal of Clinical Investigation·Barbara Rehermann
Mar 3, 2007·Digestive Diseases and Sciences·Gary L DavisGyongyi Szabo
Jul 4, 2012·Advances in Virology·Maria Giovanna QuarantaStefano Vella
Mar 28, 2012·Infectious Agents and Cancer·Luigi BuonaguroFranco M Buonaguro
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Emi ShudoAlan S Perelson
Apr 21, 2009·Medicinal Research Reviews·Xinjian ZhangMarkus W Germann
Jun 29, 2007·Journal of Medical Virology·Yoshio TokumotoMorikazu Onji
Jun 29, 2011·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Guoli ShiYoshihiro Kitamura
Nov 26, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Pau Sancho-BruRamón Bataller
Dec 7, 2011·FEMS Microbiology Reviews·Robert ThimmeRalf Bartenschlager
Jan 5, 2005·Virology·Takayuki MurataKunitada Shimotohno
Aug 31, 2013·PLoS Pathogens·Marco BinderLars Kaderali
Aug 19, 2005·Nature·Jordan J Feld, Jay H Hoofnagle
Nov 21, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takeshi Saito, Michael Gale
Jan 25, 2013·Nature Reviews. Cancer·Alla ArzumanyanMark A Feitelson
Dec 31, 2014·World Journal of Gastroenterology : WJG·Kate S O'ConnorGolo Ahlenstiel
Apr 4, 2021·Viruses·Hui-Chun LiShih-Yen Lo
Jul 20, 2010·Immunotherapy·Nagendra R HegdeSrinivas V Kaveri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.